Search filters

List of works by Juan Pasquau

A review of the factors influencing antimicrobial prescribing

scientific article published on September 2013

ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study.

scientific article published on 2 November 2014

Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy.

scientific article published on 23 February 2018

Assisted reproductive technology and obstetric outcome in couples when the male partner has a chronic viral disease

scientific article published on 22 December 2013

Budget Impact Analysis of Switching to Darunavir/Ritonavir Monotherapy for HIV-Infected People in Spain

scientific article published on March 1, 2012

CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study

scientific article published on 2 November 2014

Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.

scientific article

Disseminated infection with Mycobacterium avium complex in immunocompetent patients

scientific article published in August 2000

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority tri

scientific article published on 7 June 2015

Duration of antimicrobial therapy

scientific article

Effect of Monotherapy with Darunavir/Ritonavir on Viral Load in Seminal Fluid, and Quality Parameters of Semen in HIV-1-Positive Patients.

scientific article published on 21 July 2016

Effect of monotherapy with darunavir/cobicistat on viral load and semen quality of HIV-1 patients.

scientific article published on 24 April 2018

Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study)

article

Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting.

scientific article published on 24 February 2014

Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.

scientific article

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study.

scientific article

Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.

scientific article published on 30 December 2016

Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.

scientific article published on 24 October 2008

High prevalence and diversity of HIV-1 non-B genetic forms due to immigration in southern Spain: A phylogeographic approach

scientific article

High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.

scientific article

High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial.

scientific article published on 12 April 2018

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.

scientific article

Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia

scientific article published on 08 August 2013

Liver toxicity of antiretroviral combinations including fosamprenavir plus ritonavir 1400/100 mg once daily in HIV/hepatitis C virus-coinfected patients.

scientific article published on 20 June 2011

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis.

scientific article

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.

scientific article published on January 2008

Monotherapy with darunavir/ritonavir is effective and safe in clinical practice

scientific article published on 2 November 2014

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

scholarly article by Ignacio Pérez-Valero et al published 11 June 2018 in Journal of Antimicrobial Chemotherapy

Nuke-Sparing Regimens for the Long-Term Care of HIV Infection

scientific article published on October 2015

Phylodynamic and Phylogeographic Profiles of Subtype B HIV-1 Epidemics in South Spain

scientific article

Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH

scientific article published on 01 December 2011

Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document

scientific article published on 15 December 2011

Randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy

scientific article

Resistencias genotípicas en pacientes con VIH-1 y grados de viremia persistentemente bajos

scientific article published on 13 February 2009

Risk factors for infection by oncogenic human papillomaviruses in HIV-positive MSM patients in the ART era (2010-2016).

scientific article published on September 2017

Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

scientific article

Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM)

scientific article

Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes

scientific article published on 12 May 2015

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferio

scientific article published on 13 September 2016

Study of human immunodeficiency virus transmission chains in Andalusia: analysis from baseline antiretroviral resistance sequences

scientific article published on 31 January 2015

The efficacy and safety of maraviroc addition to a stable antiretroviral regimen in subjects with suppressed plasma HIV-RNA is not influenced by age.

scientific article

The role of antimicrobial stewardship programs in the control of bacterial resistance

scientific article

Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B

article

[Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan].

scientific article published on 18 January 2017

[Endocarditis due to Mycoplasma hominis]

scientific article published on 01 August 2006

[Hafnia alvei bacteremia in an AIDS patient]

scientific article published on 01 May 1997

Paulina is supported by:

About Paulina

Help